RecruitingNCT03001180

Identification of Biomarkers for Patients with Vascular Anomalies

Sponsor

Children's Hospital Medical Center, Cincinnati

Enrollment

1,000 participants

Start Date

Apr 1, 2015

Study Type

OBSERVATIONAL

Conditions

Vascular Anomaly Klippel Trenaunay Syndrome Kaposiform Hemangioendothelioma Generalized Lymphatic Anomaly Kaposiform Lymphangiomatosis Gorham-Stout Disease Congenital Lipomatous Overgrowth, Vascular Malformations, and Epidermal Nevi

Summary

The study will use blood (serum and plasma) and tissue obtained from participants undergoing prescribed surgical resection of vascular anomalies of interest proposed in this study. The study will also use blood (serum and plasma) and tissue collected and stored in a tissue bank maintained by the Department of Hematology/Oncology.

Eligibility

Min Age: 1 Day

Inclusion Criteria2

Any patient having labs drawn as standard of care will have blood drawn for the study if consented/ assented.
All patients who are undergoing a surgical procedure or sclerotherapy are currently consented for participation in the tissue bank.